Please use this identifier to cite or link to this item:
https://doi.org/10.1158/1078-0432.CCR-06-0774
DC Field | Value | |
---|---|---|
dc.title | Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications | |
dc.contributor.author | Yao, X | |
dc.contributor.author | Qian, C.-N | |
dc.contributor.author | Zhang, Z.-F | |
dc.contributor.author | Tan, M.-H | |
dc.contributor.author | Kort, E.J | |
dc.contributor.author | Yang, X.J | |
dc.contributor.author | Resau, J.H | |
dc.contributor.author | Teh, B.T | |
dc.date.accessioned | 2020-10-27T07:02:05Z | |
dc.date.available | 2020-10-27T07:02:05Z | |
dc.date.issued | 2007 | |
dc.identifier.citation | Yao, X, Qian, C.-N, Zhang, Z.-F, Tan, M.-H, Kort, E.J, Yang, X.J, Resau, J.H, Teh, B.T (2007). Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clinical Cancer Research 13 (1) : 161-169. ScholarBank@NUS Repository. https://doi.org/10.1158/1078-0432.CCR-06-0774 | |
dc.identifier.issn | 1078-0432 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/181048 | |
dc.description.abstract | Purpose: Intratumoral microvascular density (MVD) has been controversial as an indicator of prognosis in clear cell renal cell carcinoma (CCRCC). Classification of the intratumoral blood vessels based on differential expressions of blood vessel markers has not been correlated with patient prognosis in CCRCC. In this study, we aimed to evaluate the association of different categories of blood vessels with the patients' outcomes. Experimental Design: Seventy-eight CCRCC patients who underwent nephrectomy alone were enrolled. Paraffin-embedded CCRCC tissues, together with 16 nonmalignant kidney cortex tissues, were used in tissue microarray analyses and conventional section analyses. The characteristics of intratumoral blood vessels were identified by multiple blood vessel markers and pericyte markers. A computerized image analysis program was used to quantitatively calculate the vascular density. Results: Two distinct types of microvessels were identified in CCRCC: undifferentiated (CD31+/ CD34-) and differentiated (CD34+) vessels. A higher undifferentiated MVD significantly correlated with higher tumor grades and shorter patient survival. In contrast, a higher differentiated MVD significantly correlated with lower tumor grade and longer survival. Multivariate analyses showed that undifferentiated MVD was an independent prognostic factor for patient survival. An inverse correlation between undifferentiated MVD and differentiated MVD was also identified in CCRCC. Conclusions: This is the first report showing distinct types of vasculature in CCRCC correlated with contrasting prognoses. A refined classification of CCRCC based on vasculature is therefore important for evaluating prognosis, and it may also have therapeutic implications. © 2007 American Association for Cancer Research. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | CD31 antigen | |
dc.subject | CD34 antigen | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | blood vessel | |
dc.subject | cancer grading | |
dc.subject | cancer survival | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | image analysis | |
dc.subject | kidney carcinoma | |
dc.subject | kidney parenchyma | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | nephrectomy | |
dc.subject | pericyte | |
dc.subject | priority journal | |
dc.subject | prognosis | |
dc.subject | tissue microarray | |
dc.subject | tumor vascularization | |
dc.subject | Aged | |
dc.subject | Antigens, CD31 | |
dc.subject | Antigens, CD34 | |
dc.subject | Blood Vessels | |
dc.subject | Carcinoma, Renal Cell | |
dc.subject | Disease-Free Survival | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Immunohistochemistry | |
dc.subject | Kidney | |
dc.subject | Male | |
dc.subject | Microcirculation | |
dc.subject | Middle Aged | |
dc.subject | Neovascularization, Pathologic | |
dc.subject | Oligonucleotide Array Sequence Analysis | |
dc.subject | Prognosis | |
dc.subject | Treatment Outcome | |
dc.type | Article | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.1158/1078-0432.CCR-06-0774 | |
dc.description.sourcetitle | Clinical Cancer Research | |
dc.description.volume | 13 | |
dc.description.issue | 1 | |
dc.description.page | 161-169 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1158_1078-0432_CCR-06-0774.pdf | 544.74 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License